Evidence map›Paper›PMID 11021597›Full record

ArticleGene therapy2000

Retargeting of adenoviral vectors to neurons using the Hc fragment of tetanus toxin.

H Schneider, M Groves, C Mühle, P N Reynolds, A Knight, M Themis, J Carvajal, F Scaravilli, D T Curiel, N F Fairweather and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

H SchneiderDivision of Biomedical Sciences, Imperial College School of Medicine, London, UK.
M Groves
C Mühle
P N Reynolds
A Knight
M Themis
J Carvajal
F Scaravilli
D T Curiel
N F Fairweather
C Coutelle
Imperial College London · GBUniversity College London · GBUniversity of Alabama at Birmingham · USNIHR Imperial Biomedical Research Centre · GB

Funding

ADENOVIRAL MEDIATED TARGETED GENE DELIVERYR01CA074242 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURIEL, DAVID T · 1997 to 2001
$416k
TARGETED VECTORS FOR CYSTIC FIBROSIS GENE THERAPYR01HL050255 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CURIEL, DAVID T · 1992 to 2000
$266k
GENE THERAPY FOR OVARIAN CANCERR01CA068245 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURIEL, DAVID T · 1996 to 1999
–
NCI NIH HHS R01 CA68245NCI NIH HHS R01 CA74242NHLBI NIH HHS R01 HL50255
6 · The paper itself

Abstract

The Hc fragment of tetanus toxin (Hc) retains the specific nerve cell binding and transport properties of the holotoxin, but lacks any toxicity. We are investigating the potential for utilising its neurotropism for targeted gene delivery to the central nervous system. Previously we reported the use of Hc-polylysine conjugates for selective gene transfer into neuronal cells in vitro. However, as attempts to apply these constructs in vivo were not successful, we have extended these studies to modification of the tropism of adenoviral vectors. Either Hc-polylysine conjugates or the Fab fragment of a neutralising anti-knob antibody covalently bound to Hc were attached to the virus. Infection of neuronal and non-neuronal cell lines with retargeted virus showed highly increased neuronal cell selectivity, but no significant enhancement of gene delivery into these cells. High concentrations of free Hc blocked the infectivity of the retargeted vector efficiently. Intramuscular injection of retargeted virus into mouse tongues resulted in selective gene transfer to the neurons of the hypoglossal nucleus, where no pathological changes were observed. As differentiated neurons do not undergo cell division, appropriate vectors carrying a thymidine kinase gene, which allows selective elimination of dividing cells, may be exploitable for the treatment of tumours of the central nervous system. The demonstrated suitability of the Hc fragment of tetanus toxin as targeting moiety for viral vectors also indicates a potential for gene therapy of inherited neurodegenerative diseases such as spinal muscular atrophy.

Indexed as

Motor NeuronsPeptide FragmentsTetanus ToxinAdenoviridaeAnimalsbeta-GalactosidaseCentral Nervous System DiseasesGene ExpressionGenetic EngineeringGenetic TherapyGenetic VectorsHistocytochemistryHybridomasInjectionsMiceMice, Inbred Strainsbeta-GalactosidasePeptide FragmentsPolylysineTetanus Toxintetanus toxin fragment C

Identifiers

PMID11021597
OpenAlexW1970983540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.